JN

Jyoti Nilesh Bankar

Active Director Director DIN 08865599
DIN 08865599 First appointment Sep 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Jyoti Nilesh Bankar

Data last updated:

Jyoti Nilesh Bankar is a Director at Pharmac Drugs Private Limited (since 2020). The company operates in Trading. Pharmac Drugs Private Limited reported revenue of ₹1.50 Cr (FY 2025).

DIN 08865599
Primary Designation Director
Industry Trading
First Appointment 07 Sep 2020
Oldest Company Age 11 yrs
Largest company Pharmac Drugs Private Limited · ₹1.50 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmac Drugs Private Limited U51909PN2015PTC154577
Director07 Sep 20202015₹1.50 Cr (FY 2025)Active

Board colleagues of Jyoti Nilesh Bankar

Directorship timeline

Open interactive timeline →
Pharmac Drugs Private Limited
Premium access

Shareholding and investment profile for Jyoti Nilesh Bankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Nilesh Bankar

Jyoti Nilesh Bankar currently holds 1 directorship: Pharmac Drugs Private Limited (Director, since 07 Sep 2020, revenue ₹1.50 Cr (FY 2025)).

Jyoti Nilesh Bankar was first appointed on 07 Sep 2020 as Director at Pharmac Drugs Private Limited.

The current boards of Jyoti Nilesh Bankar's companies include Jayshri Prashant Devrat (Pharmac Drugs Private Limited), Vijay Bapu Lokhande (Pharmac Drugs Private Limited), Yogesh Shantaram Ugale (Pharmac Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available